Of new genetic models, recent data showed that levetiracetam significantly reduced ECoG spike frequency medication in a mouse model of potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1 (HCN1) developmental and epileptic encephalopathy [69]. Here, HCN1 is linked to Epileptic encephalopathy.